Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BJEXF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
IMB-102
|
|||||
| Synonyms |
IMB 102; IMB102
Click to Show/Hide
|
|||||
| Organization |
ImmunoBiochem Corp.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Cathepsin D (CTSD)
|
Antigen Info | ||||
| Payload Name |
Mertansine DM4
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
|
Linker Info | ||||
| Conjugate Type |
Lysine residue on the antibody is conjugated via an amide bond to the linker-payload moiety.
|
|||||
| Combination Type |
Ravtansine
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.